Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Needs to learn the lessons of existing screening programmes
| The first 150 words of the full text of this article appear below. |
Retinopathy is the biggest single cause of blindness in the United Kingdom.1 Laser coagulation of high risk lesions detected by screening can significantly reduce the likelihood of blindness and deteriorating vision. 2 3 Screening for diabetic retinopathy has been available in some areas of the United Kingdom since the late 1980s, but access is uneven, screening techniques of differing effectiveness have been used, 3 4 quality assurance may not be an integral part, and the resources available are variable. A national screening programme has now been recommended, but several organisational issues need to be tackled if this programme is not to repeat the problems incurred by earlier national screening programmes.
In 1999 the UK National Screening Committee asked the British
Diabetic Association (now Diabetes UK) to convene an advisory panel to
produce a model for a cost effective national screening programme. The
panel's recommendations are now published on the national screening
committee's website
(www.diabetic-retinopathy.screening.nhs.uk/index.html
Read all Rapid Responses